Celgene (CELG) Stockholders Approve Acquisition by Bristol-Myers Squibb (BMY)

April 12, 2019 10:34 AM
Celgene Corporation (NASDAQ: CELG) today announced that its stockholders have voted to approve the company’s proposed combination with Bristol-Myers Squibb ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)


Corporate News Management Comments Mergers and Acquisitions

Next Articles